Weng, Xiaocheng
Gong, Jing
Chen, Yi
Wu, Tong
Wang, Fang
Yang, Shixi
Yuan, Yushu
Luo, Guanzheng http://orcid.org/0000-0002-6797-9319
Chen, Kai
Hu, Lulu
Ma, Honghui
Wang, Pingluan
Zhang, Qiangfeng Cliff http://orcid.org/0000-0002-4913-0338
Zhou, Xiang
He, Chuan http://orcid.org/0000-0003-4319-7424
Funding for this research was provided by:
National Natural Science Foundation of China (21572172, 21778040, 21822704, 31671355, 91740204, 31761163007, 21432008, 91753201, 21721005)
U.S. Department of Health & Human Services | National Institutes of Health (HG008935)
Howard Hughes Medical Institute
Article History
Received: 19 January 2019
Accepted: 20 December 2019
First Online: 3 February 2020
Competing interests
: C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics, Inc., and a shareholder of Epican Genetech.